Deutetrabenazine (Teva Neuroscience, Inc, Parsippany, NJ) is a VMAT2 inhibitor approved by the USFDA in adults for treatment of TD and chorea associated with HD.18 The gene discussed is SLC18A2; the disease is choreatic disease.